Novel Sulfamide Analogs of Oleoylethanolamide Showing In Vivo Satiety Inducing Actions and PPARα Activation

Journal of Medicinal Chemistry
2007.0

Abstract

Long chain saturated and unsaturated alkyl sulfamide and propyl sulfamide derivatives, analogs of oleoylethanolamide, have been synthesized and evaluated in vivo and in vitro as peroxisome proliferator activated receptor alpha (PPARalpha) activators. Additionally, the anorexic effects of the new compounds have been studied in vivo in food-deprived rats. Among the active compounds N-octadecyl-N'-propylsulfamide (7) has been identified as a potent hypolipidemic compound, a potent feeding suppressant, and a concentration-dependent activator of PPARalpha.

Knowledge Graph

Similar Paper

Novel Sulfamide Analogs of Oleoylethanolamide Showing In Vivo Satiety Inducing Actions and PPARα Activation
Journal of Medicinal Chemistry 2007.0
Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonists
Bioorganic & Medicinal Chemistry Letters 2015.0
Design and synthesis of indane-ureido-thioisobutyric acids: A novel class of PPARα agonists
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide
European Journal of Medicinal Chemistry 2009.0
ω-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents
Bioorganic & Medicinal Chemistry 2008.0
Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia
Journal of Medicinal Chemistry 2005.0
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists
European Journal of Medicinal Chemistry 2016.0
Evaluation of synthetic sphingolipid analogs as ligands for peroxisome proliferator-activated receptors
Bioorganic & Medicinal Chemistry Letters 2009.0
Novel Acylethanolamide Derivatives That Modulate Body Weight through Enhancement of Hypothalamic Pro-Opiomelanocortin (POMC) and/or Decreased Neuropeptide Y (NPY)
Journal of Medicinal Chemistry 2013.0
Design and Synthesis of the First Generation of Dithiolane Thiazolidinedione- and Phenylacetic Acid-Based PPARγ Agonists
Journal of Medicinal Chemistry 2006.0